| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 09/16/2009 | EP2099765A2 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives as antitumor agents |
| 09/16/2009 | EP2099764A1 Preparation of substituted morphinan-6-ones and salts and intermediates thereof |
| 09/16/2009 | EP2099745A2 Preparation of 3,4-dihydroisoquinolines from an acid and an amine |
| 09/16/2009 | EP2099303A1 Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | CN100540537C Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
| 09/16/2009 | CN100540534C N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 09/11/2009 | WO2009109648A1 Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring |
| 09/11/2009 | WO2009073545A3 Tetrahydro-isoquinoline ppat inhibitors as antibacterial agents |
| 09/11/2009 | WO2009015067A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/11/2009 | CA2716664A1 Oxadiazoanthracene compounds for the treatment of diabetes |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/09/2009 | EP2098511A1 Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring |
| 09/09/2009 | EP1809284A4 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/09/2009 | EP1567477B1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/09/2009 | CN101528703A 2-(1-oxo-1H-isoquinolin-2-yl) acetamide derivatives |
| 09/09/2009 | CN100537534C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585885 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585574 Pyrene derivative and organic electroluminescence device making use of the same |
| 09/08/2009 | CA2287558C Heterocyclic derivatives and their use as antithrombotic agents |
| 09/08/2009 | CA2213466C Inhibitors of microsomal triglyceride transfer protein and method |
| 09/03/2009 | WO2009106547A1 Process for the resolution of isoquinoline derivatives |
| 09/03/2009 | US20090221829 3,4-Dihydroisoquinolinium Salt Derivatives |
| 09/03/2009 | US20090221633 Inhibitors of akt (protein kinase b) |
| 09/03/2009 | US20090221575 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | CA2708666A1 Process for the resolution of isoquinoline derivatives |
| 09/02/2009 | EP2096104A1 Organic diamines as mGluR7 modulators |
| 09/02/2009 | EP1899322B1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 09/02/2009 | CN101522633A 6-substituted isoquinoline derivatives as ROCK-I inhibitors |
| 09/02/2009 | CN101522632A Process for the preparation of substituted-1,2,3,4-tetrahydroisoquinoline derivates |
| 09/02/2009 | CN100534986C Method for preparing derivative of 1,4 - dichloro isoquinoline category |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 08/27/2009 | WO2009105206A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 08/27/2009 | US20090215764 Antimicrobial agents |
| 08/27/2009 | CA2714122A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 08/26/2009 | EP2091929A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 08/26/2009 | EP1773817B1 Substituted aryl-amine derivatives and methods of use |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/26/2009 | EP1501804B1 Isoquinoline derivatives mao-b inhibitors |
| 08/26/2009 | CN101516854A Preparation of substituted morphinan-6-ones and salts and intermediates thereof |
| 08/26/2009 | CN101516839A Compounds which modulate the cb2 receptor |
| 08/26/2009 | CN101516834A Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 08/26/2009 | CN101516833A Tartrate derivatives for use as coagulation factor IXa inhibitors |
| 08/26/2009 | CN100532362C Process for preparing N-methyl quinoline compounds by ester reaction solvent |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/20/2009 | WO2009083899A3 Process for the preparation of an enantiomeric trisubstituted 3,4-dihydro-isoquinoline derivative |
| 08/20/2009 | WO2009074733A3 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same |
| 08/20/2009 | US20090209765 Process for production of 4-fluoroisoquinoline-5-sulfonyl halide or salt thereof |
| 08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
| 08/20/2009 | US20090209528 Substituted tetrahydroisoquinoline compound, their preparation and use in medicaments |
| 08/20/2009 | US20090206326 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 08/19/2009 | EP2090566A2 Certain phenylacetic acids and derivatives |
| 08/19/2009 | EP2089417A2 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 08/19/2009 | EP1999113B1 Substituted 1-amino-4-phenyl-dihydroisoquinolines, method for the production thereof, use thereof as a medicament, and medicaments containing them |
| 08/19/2009 | CN100528879C S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method |
| 08/18/2009 | US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide |
| 08/18/2009 | US7575816 Ln( beta -enolate)3(mono-imine) where in mono-imine is selected from 3-cyanopyridine; 2-dimethylaminopyridine; isoquinoline; 4-tertbutyl-pyridine; 4-phenylpyridine; and 2-(2-thienyl)pyridine, Ln is selected from Eu, Tb and Tm; beta -enolate such as 2,4-pentanedionate |
| 08/13/2009 | WO2009019534A3 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 08/12/2009 | EP1624868B9 "(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)- propyl]phenyl derivatives as beta2 agonists |
| 08/12/2009 | CN101506171A Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 08/12/2009 | CN101506168A Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
| 08/12/2009 | CN101503391A 1,2-dihydroisoquinoline derivative and preparation thereof |
| 08/12/2009 | CN100526277C Method for the treatment or prevention of lower urinary tract symptoms |
| 08/11/2009 | US7572913 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572787 Substituted naphthalene sulfonamides |
| 08/11/2009 | US7572783 Obesity; N-(1-benzyl-piperidin-4-yl)-2-(2,5-dioxo-7-phenoxy-1,2,3,5-tetrahydro-benzo[e][1,4]diazepin-4-yl)-3-methyl-butyramide; modulators of ghrelin receptor (GHSR) |
| 08/11/2009 | CA2449402C Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 08/06/2009 | WO2009097433A1 Novel dyes and use thereof in imaging members and methods |
| 08/06/2009 | WO2009096526A1 Carboxylic acid compound or salt thereof |
| 08/06/2009 | WO2008103354A3 Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| 08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | CN101501001A Processes for optical resolution of 1-phenyl-1,2,3,4-tetrahydroisoquinoline |
| 08/05/2009 | CN101500997A PARP inhibitors |
| 08/05/2009 | CN101497584A Isoquinoline-3-formyl amino acid formyl amino acid benzyl ester, as well as preparation and use thereof |
| 08/05/2009 | CN100522946C Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/04/2009 | US7569678 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 07/30/2009 | US20090192188 Tetrahydroisoquinoline derivatives |
| 07/29/2009 | EP2081905A2 Sulfonyl compounds which modulate the cb2 receptor |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/28/2009 | US7566726 3-Trifluoromethyl,6-((3-(methyl,4-hydroxytetrahydropyran-4-yl)-amino-(3-isopropyl-cyclopent-1,3-ylene))-carbonyl-)-5,6,7,8-tetrahydro-1,6-naphthyridine; antiinflammatory agents; immunomodulators; antiallergens; rhintis; dermatitis; conjunctivits, asthma; autoimmune diseases; antiarthritis agents |
| 07/23/2009 | WO2009091898A2 6-and 7-amino isoquinoline compounds and methods for making and using the same |
| 07/23/2009 | WO2008076427A3 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 07/23/2009 | US20090186917 6-And 7-amino isoquinoline compounds and methods for making and using the same |
| 07/23/2009 | CA2712443A1 6- and 7-amino isoquinoline compounds and methods for making and using the same |
| 07/22/2009 | CN101490007A VR1 vanilloid receptor antagonists with a iononic substructure |
| 07/22/2009 | CN101490006A Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 07/16/2009 | WO2009089083A1 Trpa1 antagonists |
| 07/16/2009 | WO2009088990A1 Certain chemical entities, compositions and methods |
| 07/16/2009 | WO2009088986A1 Certain chemical entities, compositions and methods |
| 07/16/2009 | WO2009087649A1 Renin inhibitors |
| 07/16/2009 | CA2711558A1 Certain chemical entities, compositions and methods |
| 07/16/2009 | CA2711446A1 Certain chemical entities, compositions and methods |
| 07/16/2009 | CA2711159A1 Trpa1 antagonists |
| 07/14/2009 | US7560463 Diaryl ethers as opioid receptor antagonists |